Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report)’s share price shot up 0.1% during trading on Monday . The company traded as high as $8.63 and last traded at $8.49. 1,416,883 shares traded hands during mid-day trading, an increase of 263% from the average session volume of 390,347 shares. The stock had previously closed at $8.48.
Coloplast A/S Price Performance
The business’s 50 day moving average price is $9.01 and its 200 day moving average price is $9.25. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.00 and a current ratio of 1.61.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.02). The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. As a group, equities analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.
About Coloplast A/S
Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.
In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.
Recommended Stories
- Five stocks we like better than Coloplast A/S
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
- How to Capture a Slice of the Starlink IPO Buzz
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
